Global Viral and Non-Viral Vector Manufacturing Market Growth (Status and Outlook) 2024-2031

Report ID: 1545854 | Published Date: Jan 2025 | No. of Page: 121 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Viral and Non-Viral Vector Manufacturing Market Size 2017-2028
        2.1.2 Viral and Non-Viral Vector Manufacturing Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Viral and Non-Viral Vector Manufacturing Segment by Type
        2.2.1 Viral Vectors
        2.2.2 Non-Viral Vectors
    2.3 Viral and Non-Viral Vector Manufacturing Market Size by Type
        2.3.1 Viral and Non-Viral Vector Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)
    2.4 Viral and Non-Viral Vector Manufacturing Segment by Application
        2.4.1 Gene Therapy
        2.4.2 Vaccinology
        2.4.3 Cell Therapy
        2.4.4 Others
    2.5 Viral and Non-Viral Vector Manufacturing Market Size by Application
        2.5.1 Viral and Non-Viral Vector Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)
3 Viral and Non-Viral Vector Manufacturing Market Size by Player
    3.1 Viral and Non-Viral Vector Manufacturing Market Size Market Share by Players
        3.1.1 Global Viral and Non-Viral Vector Manufacturing Revenue by Players (2020-2022)
        3.1.2 Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Players (2020-2022)
    3.2 Global Viral and Non-Viral Vector Manufacturing Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Viral and Non-Viral Vector Manufacturing by Regions
    4.1 Viral and Non-Viral Vector Manufacturing Market Size by Regions (2017-2022)
    4.2 Americas Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)
    4.3 APAC Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)
    4.4 Europe Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)
    4.5 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022)
    5.2 Americas Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)
    5.3 Americas Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022)
    6.2 APAC Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)
    6.3 APAC Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Viral and Non-Viral Vector Manufacturing by Country (2017-2022)
    7.2 Europe Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)
    7.3 Europe Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Viral and Non-Viral Vector Manufacturing by Region (2017-2022)
    8.2 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022)
    8.3 Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Viral and Non-Viral Vector Manufacturing Market Forecast
    10.1 Global Viral and Non-Viral Vector Manufacturing Forecast by Regions (2023-2028)
        10.1.1 Global Viral and Non-Viral Vector Manufacturing Forecast by Regions (2023-2028)
        10.1.2 Americas Viral and Non-Viral Vector Manufacturing Forecast
        10.1.3 APAC Viral and Non-Viral Vector Manufacturing Forecast
        10.1.4 Europe Viral and Non-Viral Vector Manufacturing Forecast
        10.1.5 Middle East & Africa Viral and Non-Viral Vector Manufacturing Forecast
    10.2 Americas Viral and Non-Viral Vector Manufacturing Forecast by Country (2023-2028)
        10.2.1 United States Viral and Non-Viral Vector Manufacturing Market Forecast
        10.2.2 Canada Viral and Non-Viral Vector Manufacturing Market Forecast
        10.2.3 Mexico Viral and Non-Viral Vector Manufacturing Market Forecast
        10.2.4 Brazil Viral and Non-Viral Vector Manufacturing Market Forecast
    10.3 APAC Viral and Non-Viral Vector Manufacturing Forecast by Region (2023-2028)
        10.3.1 China Viral and Non-Viral Vector Manufacturing Market Forecast
        10.3.2 Japan Viral and Non-Viral Vector Manufacturing Market Forecast
        10.3.3 Korea Viral and Non-Viral Vector Manufacturing Market Forecast
        10.3.4 Southeast Asia Viral and Non-Viral Vector Manufacturing Market Forecast
        10.3.5 India Viral and Non-Viral Vector Manufacturing Market Forecast
        10.3.6 Australia Viral and Non-Viral Vector Manufacturing Market Forecast
    10.4 Europe Viral and Non-Viral Vector Manufacturing Forecast by Country (2023-2028)
        10.4.1 Germany Viral and Non-Viral Vector Manufacturing Market Forecast
        10.4.2 France Viral and Non-Viral Vector Manufacturing Market Forecast
        10.4.3 UK Viral and Non-Viral Vector Manufacturing Market Forecast
        10.4.4 Italy Viral and Non-Viral Vector Manufacturing Market Forecast
        10.4.5 Russia Viral and Non-Viral Vector Manufacturing Market Forecast
    10.5 Middle East & Africa Viral and Non-Viral Vector Manufacturing Forecast by Region (2023-2028)
        10.5.1 Egypt Viral and Non-Viral Vector Manufacturing Market Forecast
        10.5.2 South Africa Viral and Non-Viral Vector Manufacturing Market Forecast
        10.5.3 Israel Viral and Non-Viral Vector Manufacturing Market Forecast
        10.5.4 Turkey Viral and Non-Viral Vector Manufacturing Market Forecast
        10.5.5 GCC Countries Viral and Non-Viral Vector Manufacturing Market Forecast
    10.6 Global Viral and Non-Viral Vector Manufacturing Forecast by Type (2023-2028)
    10.7 Global Viral and Non-Viral Vector Manufacturing Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Boehringer Ingelheim
        11.1.1 Boehringer Ingelheim Company Information
        11.1.2 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product Offered
        11.1.3 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Boehringer Ingelheim Main Business Overview
        11.1.5 Boehringer Ingelheim Latest Developments
    11.2 Catalent, Inc.
        11.2.1 Catalent, Inc. Company Information
        11.2.2 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product Offered
        11.2.3 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Catalent, Inc. Main Business Overview
        11.2.5 Catalent, Inc. Latest Developments
    11.3 FUJIFILM Holdings Corporation
        11.3.1 FUJIFILM Holdings Corporation Company Information
        11.3.2 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product Offered
        11.3.3 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 FUJIFILM Holdings Corporation Main Business Overview
        11.3.5 FUJIFILM Holdings Corporation Latest Developments
    11.4 Danaher Corporation
        11.4.1 Danaher Corporation Company Information
        11.4.2 Danaher Corporation Viral and Non-Viral Vector Manufacturing Product Offered
        11.4.3 Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Danaher Corporation Main Business Overview
        11.4.5 Danaher Corporation Latest Developments
    11.5 Genscript Biotech Corporation
        11.5.1 Genscript Biotech Corporation Company Information
        11.5.2 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product Offered
        11.5.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Genscript Biotech Corporation Main Business Overview
        11.5.5 Genscript Biotech Corporation Latest Developments
    11.6 Lonza Group AG
        11.6.1 Lonza Group AG Company Information
        11.6.2 Lonza Group AG Viral and Non-Viral Vector Manufacturing Product Offered
        11.6.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Lonza Group AG Main Business Overview
        11.6.5 Lonza Group AG Latest Developments
    11.7 Merck KGaA Inc.
        11.7.1 Merck KGaA Inc. Company Information
        11.7.2 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product Offered
        11.7.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Merck KGaA Inc. Main Business Overview
        11.7.5 Merck KGaA Inc. Latest Developments
    11.8 Oxford Biomedica Plc
        11.8.1 Oxford Biomedica Plc Company Information
        11.8.2 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product Offered
        11.8.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Oxford Biomedica Plc Main Business Overview
        11.8.5 Oxford Biomedica Plc Latest Developments
    11.9 Sartorius AG
        11.9.1 Sartorius AG Company Information
        11.9.2 Sartorius AG Viral and Non-Viral Vector Manufacturing Product Offered
        11.9.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Sartorius AG Main Business Overview
        11.9.5 Sartorius AG Latest Developments
    11.10 Takara Bio Inc.
        11.10.1 Takara Bio Inc. Company Information
        11.10.2 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product Offered
        11.10.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Takara Bio Inc. Main Business Overview
        11.10.5 Takara Bio Inc. Latest Developments
    11.11 Thermo Fisher Scientific Inc.
        11.11.1 Thermo Fisher Scientific Inc. Company Information
        11.11.2 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Product Offered
        11.11.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Thermo Fisher Scientific Inc. Main Business Overview
        11.11.5 Thermo Fisher Scientific Inc. Latest Developments
    11.12 Wuxi AppTec
        11.12.1 Wuxi AppTec Company Information
        11.12.2 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Product Offered
        11.12.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Wuxi AppTec Main Business Overview
        11.12.5 Wuxi AppTec Latest Developments
    11.13 Acuitas Therapeutics
        11.13.1 Acuitas Therapeutics Company Information
        11.13.2 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Product Offered
        11.13.3 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Acuitas Therapeutics Main Business Overview
        11.13.5 Acuitas Therapeutics Latest Developments
    11.14 Evonik Industries AG
        11.14.1 Evonik Industries AG Company Information
        11.14.2 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Product Offered
        11.14.3 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Evonik Industries AG Main Business Overview
        11.14.5 Evonik Industries AG Latest Developments
    11.15 Exelead, Inc.
        11.15.1 Exelead, Inc. Company Information
        11.15.2 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Product Offered
        11.15.3 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Exelead, Inc. Main Business Overview
        11.15.5 Exelead, Inc. Latest Developments
    11.16 Entos Pharmaceuticals
        11.16.1 Entos Pharmaceuticals Company Information
        11.16.2 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Product Offered
        11.16.3 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Entos Pharmaceuticals Main Business Overview
        11.16.5 Entos Pharmaceuticals Latest Developments
    11.17 Genevant Sciences GmbH
        11.17.1 Genevant Sciences GmbH Company Information
        11.17.2 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Product Offered
        11.17.3 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Genevant Sciences GmbH Main Business Overview
        11.17.5 Genevant Sciences GmbH Latest Developments
    11.18 T&T Scientific Corporation
        11.18.1 T&T Scientific Corporation Company Information
        11.18.2 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Product Offered
        11.18.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 T&T Scientific Corporation Main Business Overview
        11.18.5 T&T Scientific Corporation Latest Developments
    11.19 Moderna, Inc.
        11.19.1 Moderna, Inc. Company Information
        11.19.2 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Product Offered
        11.19.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.19.4 Moderna, Inc. Main Business Overview
        11.19.5 Moderna, Inc. Latest Developments
    11.20 CureVac N.V.
        11.20.1 CureVac N.V. Company Information
        11.20.2 CureVac N.V. Viral and Non-Viral Vector Manufacturing Product Offered
        11.20.3 CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
        11.20.4 CureVac N.V. Main Business Overview
        11.20.5 CureVac N.V. Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Viral and Non-Viral Vector Manufacturing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Viral Vectors
    Table 3. Major Players of Non-Viral Vectors
    Table 4. Viral and Non-Viral Vector Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)
    Table 7. Viral and Non-Viral Vector Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)
    Table 10. Global Viral and Non-Viral Vector Manufacturing Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Player (2020-2022)
    Table 12. Viral and Non-Viral Vector Manufacturing Key Players Head office and Products Offered
    Table 13. Viral and Non-Viral Vector Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Viral and Non-Viral Vector Manufacturing Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Country (2017-2022)
    Table 20. Americas Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)
    Table 22. Americas Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)
    Table 24. APAC Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region (2017-2022)
    Table 26. APAC Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)
    Table 28. APAC Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)
    Table 30. Europe Viral and Non-Viral Vector Manufacturing Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Country (2017-2022)
    Table 32. Europe Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)
    Table 34. Europe Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Viral and Non-Viral Vector Manufacturing
    Table 43. Key Market Challenges & Risks of Viral and Non-Viral Vector Manufacturing
    Table 44. Key Industry Trends of Viral and Non-Viral Vector Manufacturing
    Table 45. Global Viral and Non-Viral Vector Manufacturing Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Viral and Non-Viral Vector Manufacturing Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Viral and Non-Viral Vector Manufacturing Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share Forecast by Application (2023-2028)
    Table 51. Boehringer Ingelheim Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 52. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product Offered
    Table 53. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. Boehringer Ingelheim Main Business
    Table 55. Boehringer Ingelheim Latest Developments
    Table 56. Catalent, Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 57. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product Offered
    Table 58. Catalent, Inc. Main Business
    Table 59. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Catalent, Inc. Latest Developments
    Table 61. FUJIFILM Holdings Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 62. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product Offered
    Table 63. FUJIFILM Holdings Corporation Main Business
    Table 64. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. FUJIFILM Holdings Corporation Latest Developments
    Table 66. Danaher Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 67. Danaher Corporation Viral and Non-Viral Vector Manufacturing Product Offered
    Table 68. Danaher Corporation Main Business
    Table 69. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. Danaher Corporation Latest Developments
    Table 71. Genscript Biotech Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 72. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product Offered
    Table 73. Genscript Biotech Corporation Main Business
    Table 74. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. Genscript Biotech Corporation Latest Developments
    Table 76. Lonza Group AG Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 77. Lonza Group AG Viral and Non-Viral Vector Manufacturing Product Offered
    Table 78. Lonza Group AG Main Business
    Table 79. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. Lonza Group AG Latest Developments
    Table 81. Merck KGaA Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 82. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product Offered
    Table 83. Merck KGaA Inc. Main Business
    Table 84. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. Merck KGaA Inc. Latest Developments
    Table 86. Oxford Biomedica Plc Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 87. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product Offered
    Table 88. Oxford Biomedica Plc Main Business
    Table 89. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Oxford Biomedica Plc Latest Developments
    Table 91. Sartorius AG Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 92. Sartorius AG Viral and Non-Viral Vector Manufacturing Product Offered
    Table 93. Sartorius AG Main Business
    Table 94. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Sartorius AG Latest Developments
    Table 96. Takara Bio Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 97. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product Offered
    Table 98. Takara Bio Inc. Main Business
    Table 99. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Takara Bio Inc. Latest Developments
    Table 101. Thermo Fisher Scientific Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 102. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Product Offered
    Table 103. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Thermo Fisher Scientific Inc. Main Business
    Table 105. Thermo Fisher Scientific Inc. Latest Developments
    Table 106. Wuxi AppTec Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 107. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Product Offered
    Table 108. Wuxi AppTec Main Business
    Table 109. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Wuxi AppTec Latest Developments
    Table 111. Acuitas Therapeutics Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 112. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Product Offered
    Table 113. Acuitas Therapeutics Main Business
    Table 114. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 115. Acuitas Therapeutics Latest Developments
    Table 116. Evonik Industries AG Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 117. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Product Offered
    Table 118. Evonik Industries AG Main Business
    Table 119. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 120. Evonik Industries AG Latest Developments
    Table 121. Exelead, Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 122. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Product Offered
    Table 123. Exelead, Inc. Main Business
    Table 124. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 125. Exelead, Inc. Latest Developments
    Table 126. Entos Pharmaceuticals Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 127. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Product Offered
    Table 128. Entos Pharmaceuticals Main Business
    Table 129. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 130. Entos Pharmaceuticals Latest Developments
    Table 131. Genevant Sciences GmbH Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 132. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Product Offered
    Table 133. Genevant Sciences GmbH Main Business
    Table 134. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 135. Genevant Sciences GmbH Latest Developments
    Table 136. T&T Scientific Corporation Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 137. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Product Offered
    Table 138. T&T Scientific Corporation Main Business
    Table 139. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 140. T&T Scientific Corporation Latest Developments
    Table 141. Moderna, Inc. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 142. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Product Offered
    Table 143. Moderna, Inc. Main Business
    Table 144. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 145. Moderna, Inc. Latest Developments
    Table 146. CureVac N.V. Details, Company Type, Viral and Non-Viral Vector Manufacturing Area Served and Its Competitors
    Table 147. CureVac N.V. Viral and Non-Viral Vector Manufacturing Product Offered
    Table 148. CureVac N.V. Main Business
    Table 149. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 150. CureVac N.V. Latest Developments
List of Figures
    Figure 1. Viral and Non-Viral Vector Manufacturing Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Viral and Non-Viral Vector Manufacturing Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type in 2021
    Figure 7. Viral and Non-Viral Vector Manufacturing in Gene Therapy
    Figure 8. Global Viral and Non-Viral Vector Manufacturing Market: Gene Therapy (2017-2022) & ($ Millions)
    Figure 9. Viral and Non-Viral Vector Manufacturing in Vaccinology
    Figure 10. Global Viral and Non-Viral Vector Manufacturing Market: Vaccinology (2017-2022) & ($ Millions)
    Figure 11. Viral and Non-Viral Vector Manufacturing in Cell Therapy
    Figure 12. Global Viral and Non-Viral Vector Manufacturing Market: Cell Therapy (2017-2022) & ($ Millions)
    Figure 13. Viral and Non-Viral Vector Manufacturing in Others
    Figure 14. Global Viral and Non-Viral Vector Manufacturing Market: Others (2017-2022) & ($ Millions)
    Figure 15. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021
    Figure 16. Global Viral and Non-Viral Vector Manufacturing Revenue Market Share by Player in 2021
    Figure 17. Global Viral and Non-Viral Vector Manufacturing Market Size Market Share by Regions (2017-2022)
    Figure 18. Americas Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)
    Figure 19. APAC Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)
    Figure 20. Europe Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)
    Figure 21. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size 2017-2022 ($ Millions)
    Figure 22. Americas Viral and Non-Viral Vector Manufacturing Value Market Share by Country in 2021
    Figure 23. Americas Viral and Non-Viral Vector Manufacturing Consumption Market Share by Type in 2021
    Figure 24. Americas Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021
    Figure 25. United States Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Canada Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 27. Mexico Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Brazil Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 29. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region in 2021
    Figure 30. APAC Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021
    Figure 31. China Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Japan Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Korea Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 35. India Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Australia Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 37. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Country in 2021
    Figure 38. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type in 2021
    Figure 39. Europe Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021
    Figure 40. Germany Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 41. France Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 42. UK Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Italy Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 44. Russia Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Region in 2021
    Figure 46. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Type in 2021
    Figure 47. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size Market Share by Application in 2021
    Figure 48. Egypt Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 49. South Africa Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 50. Israel Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Turkey Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 52. GCC Country Viral and Non-Viral Vector Manufacturing Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Americas Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 54. APAC Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 55. Europe Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 56. Middle East & Africa Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 57. United States Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 58. Canada Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 59. Mexico Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 60. Brazil Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 61. China Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 62. Japan Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 63. Korea Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 64. Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 65. India Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 66. Australia Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 67. Germany Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 68. France Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 69. UK Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 70. Italy Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 71. Russia Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 72. Spain Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 73. Egypt Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 74. South Africa Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 75. Israel Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 76. Turkey Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
    Figure 77. GCC Countries Viral and Non-Viral Vector Manufacturing Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Viral and Non-Viral Vector Manufacturing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Viral and Non-Viral Vector Manufacturing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Viral and Non-Viral Vector Manufacturing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports